스트레커 반응을 촉매하는 탄수화물 촉매
    4.
    发明公开
    스트레커 반응을 촉매하는 탄수화물 촉매 失效
    催化碳酸氢盐用于反应反应

    公开(公告)号:KR1020090017244A

    公开(公告)日:2009-02-18

    申请号:KR1020070081841

    申请日:2007-08-14

    Abstract: A material that catalyzes an environmentally friendly strecker reaction is provided, and a method for producing alpha-aminonitrile using the material that catalyzes the environmentally friendly strecker reaction is provided. A carbohydrate catalyst catalyzing a strecker reaction is a compound represented by the following formula A or B. R1 and R2 of the compound of the formula B are a hydroxyl group(-OH) or a succinyl group. The R1 of the compound of the formula B is the hydroxyl group(-OH), and the R2 of the compound of the formula B is the succinyl group. A matrix of the strecker reaction in which the catalyst engages is malonaldehyde bis(phenylimine), N-benzylidene benzene sulfoneamine, or N-benzylidene-N-(diphenylmethyl)amine. The compound of the formula A is derived from X. oryzae pv. oryzae KACC 10331. The compound of the formula B is derived from Rhizobium meliloti 1021(ATCC 51124).

    Abstract translation: 提供催化环境友好的沥青路面反应的材料,并提供使用催化环境友好的沥青路面反应的材料生产α-氨基腈的方法。 催化催化剂反应的碳水化合物催化剂是由下式A或B表示的化合物。式B化合物的R 1和R 2是羟基(-OH)或琥珀酰基。 式B化合物的R1是羟基(-OH),式B化合物的R2是琥珀酰基。 催化剂接合的催化剂反应的基质是丙二醛双(苯亚胺),N-亚苄基苯磺胺或N-亚苄基-N-(二苯基甲基)胺。 式A的化合物衍生自米曲霉 米曲霉KACC 10331.式B的化合物衍生自根瘤菌根瘤菌(Rhizobium meliloti)1021(ATCC 51124)。

    비환식 석시노글리칸의 용도
    6.
    发明公开
    비환식 석시노글리칸의 용도 有权
    ACYCLIC SUCCINOGLYCAN DIMER的使用

    公开(公告)号:KR1020130113198A

    公开(公告)日:2013-10-15

    申请号:KR1020120035590

    申请日:2012-04-05

    CPC classification number: A61K47/36 A61K31/451 Y10S514/97

    Abstract: PURPOSE: Acyclic succinoglycan is provided to be used as a novel solubilizing agent and a therapeutic agent because the acyclic succinoglycan is a safe biomaterial. CONSTITUTION: A solubilizing composition contains compounds of chemical formula 1 as an active ingredient. The compound is derived from Sinorhizobium melioti. The composition contains the compound of chemical formula 1 and a therapeutic drug. The therapeutic drug is haloperidol.

    Abstract translation: 目的:提供非环状琥珀酰聚糖作为新型增溶剂和治疗剂,因为无环琥珀酰聚糖是安全的生物材料。 构成:增溶组合物含有化学式1的化合物作为活性成分。 该化合物衍生自中华根瘤菌(Sinorhizobium melioti)。 该组合物含有化学式1的化合物和治疗药物。 治疗药物是氟哌啶醇。

Patent Agency Ranking